MAGENTA THERAPEUTICS
Magenta is focused on improving the patient experience in transplant medicine, with the goal of bringing this lifesaving procedure to more patients. Over the past 50 years, stem cell transplantation has been used in more than 1M patients worldwide. It is currently the only treatment with the potential to cure some of the most devastating hematologic cancers and autoimmune diseases. Despite the increased use and clinical advancements over the past several decades, stem cell transplant remains a high-risk last-resort therapeutic option due to the toxicity and potential long-term side effects.
MAGENTA THERAPEUTICS
Industry:
Biotechnology Medical Therapeutics
Founded:
2015-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.magentatx.com
Total Employee:
51+
Status:
Active
Contact:
857.242.0170
Total Funding:
305.9 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Abata Therapeutics
Abata Therapeutics is a biotech company.
Aspen Neuroscience
Aspen Neuroscience is a biotechnology company that specializes in personalized cell therapies.
Rakuten Medical
Rakuten Medical is a Bio-technology Company.
Beam Therapeutics
Beam Therapeutics is a biotechnology company developing precision genetic medicines through the use of base editing technology.
Cell Guidance Systems
Cell Guidance Systems is a biotechnology company developing research tools for stem cell technology.
Chroma Medicine
Chroma Medicine is a new genomic medicine company working on epigenetic editing.
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Enable Therapeutics
Enable Therapeutics is a biotechnology company developing a patented drug delivery platform.
eureKARE
eureKARE is focused on financing and building biotechnology companies in the cutting-edge fields of microbiome and synthetic biology.
Maze Therapeutics
Maze Therapeutics is an operator of a biotechnology firm used to focus on translating genetic insights into new medicines.
Monte Rosa Therapeutics
Monte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Ceptur Therapeutics
Revolutionizing gene silencing by developing targeted oligonucleotide therapeutics based on U1 Adaptor technology
Tango Therapeutics
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Theranica
Theranica is an Israeli biomedical technology company focused on developing electronic and wireless communication technology.
Zymeworks
Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics.
Current Advisors List
Board_member
2015-11-01
Board_member
Board_member
2016-11-01
Board_member
2017-10-01
Board_member
2016-01-01
Board_member
Board_member
2016-01-01
Board_member
Current Employees Featured
Alison Lawton Chair @ Magenta Therapeutics
Chair
2021-08-01
Jeffrey Humphrey Chief Medical Officer @ Magenta Therapeutics
Chief Medical Officer
2021-01-01
David Scadden Co-Founder @ Magenta Therapeutics
Co-Founder
2016-01-01
Jason Gardner CEO, President & Co-Founder @ Magenta Therapeutics
CEO, President & Co-Founder
2016-11-01
Bastiano Sanna COO @ Magenta Therapeutics
COO
Founder
Stock Details
Investors List
Great Point Partners
Great Point Partners investment in Post-IPO Equity - Magenta Therapeutics
OrbiMed
OrbiMed investment in Post-IPO Equity - Magenta Therapeutics
Janus Henderson Investors
Janus Henderson Investors investment in Post-IPO Equity - Magenta Therapeutics
TCG Crossover
TCG Crossover investment in Post-IPO Equity - Magenta Therapeutics
Deep Track Capital
Deep Track Capital investment in Post-IPO Equity - Magenta Therapeutics
Be The Match BioTherapies
Be The Match BioTherapies investment in Series C - Magenta Therapeutics
The Watermill Group
The Watermill Group investment in Series C - Magenta Therapeutics
Access Industries
Access Industries investment in Series C - Magenta Therapeutics
Casdin Capital
Casdin Capital investment in Series C - Magenta Therapeutics
EcoR1 Capital
EcoR1 Capital investment in Series C - Magenta Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-10-04 | Magenta Therapeutics Appoints Jeffrey Humphrey, M.D. as Chief Medical Officer |
Official Site Inspections
http://www.magentatx.com Semrush global rank: 3.93 M Semrush visits lastest month: 3.2 K
- Host name: 158.247.215.39.vultrusercontent.com
- IP address: 158.247.215.39
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Magenta Therapeutics"
Magenta Therapeutics - LinkedIn
Magenta Therapeutics | 12,105 followers on LinkedIn. Developing novel medicines to bring the curative power of stem cell transplants to more patients | Magenta Therapeutics is a clinical-stage ...See details»
Magenta Therapeutics and Dianthus Therapeutics Announce …
About the Proposed Transaction, Management and Organization Pre-merger Dianthus stockholders (including Dianthus stockholders issued shares of Dianthus common stock and …See details»
Magenta Therapeutics Information - RocketReach
Magenta Therapeutics is a clinical-stage biotechnology company developing medicines to bring the curative power of stem cell transplant to more patients with blood cancers, genetic …See details»
Magenta Therapeutics Company Overview, Contact Details
May 12, 2021 For more information, please visit www.magentatx.com. Follow Magenta on Twitter: @magentatx. Sign up for free to view info. Email Format Employee directory . …See details»
Magenta Therapeutics - 2025 Company Profile - Tracxn
Apr 16, 2025 Magenta Therapeutics - Developer of stem cell-based therapies for autoimmune disease, genetics blood disorders and cancer. Public Company. Raised a total funding of …See details»
Magenta Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Www.magentatx.com. Last update 08 Mar 2025. Overview. Pipeline. Deal. Translational Medicine. Profit. Grant & Funding(NIH) Investment. Financing. ... The statistics for drugs in the Pipeline …See details»
Working At Magenta Therapeutics: Company Overview and …
Mar 14, 2024 www.magentatx.com. Organization Type. Public. Social Media. Magenta is focused on improving the patient experience in transplant medicine, with the goal of bringing …See details»
Magenta Therapeutics (USA) Funding: $405.9M - Medical Startups
Apr 24, 2025 Magenta Therapeutics is a new biotechnology company developing therapeutics that unlock the power of stem cell biology. Magenta is focused on improving the patient …See details»
Magenta Therapeutics: Revenue, Worth, Valuation & Competitors …
About Magenta Therapeutics. Magenta Therapeutics is a Biotech related company founded in 2016 and based in Cambridge with 17 employees an estimated revenue of $8.5M, and. It has …See details»
Magenta Therapeutics - Crunchbase Company Profile & Funding
Contact Email investor@magentatx.com Phone Number 857.242.0170 Magenta is focused on improving the patient experience in transplant medicine, with the goal of bringing this lifesaving …See details»
Magenta Therapeutics Overview | SignalHire Company Profile
Magenta Therapeutics is a clinical-stage biotechnology company developing medicines to bring the curative power of stem cell transplant to more patients with blood cancers, genetic …See details»
Magenta’s Competitors, Revenue, Number of Employees, Funding …
Magenta’s Profile, Revenue and Employees. Magenta is a Massachusetts-based biotechnology company that researches and develops stem cell-based therapeutics for the treatment of …See details»
EX-99.1 - SEC.gov
For more information, please visit www.magentatx.com. Forward-Looking Statements . This press release contains forward-looking statements within the meaning of The Private Securities …See details»
Magenta Therapeutics - HR.com
Founded by internationally recognized leaders in stem cell transplant medicine, Magenta Therapeutics was launched in 2016 by Third Rock Ventures and Atlas Venture and is …See details»
Magenta Therapeutics - Phone, Email, Employees, CEO, VP, 2024
Founded by internationally recognized leaders in stem cell transplant medicine, Magenta Therapeutics was launched in 2016 by Third Rock Ventures and Atlas Venture and is …See details»
Magenta Therapeutics - Overview, News & Similar companies
View Magenta Therapeutics (www.magentatx.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
Magenta Therapeutics Expands Leadership Team, Appoints Kristen …
Feb 5, 2020 Magenta Therapeutics: Manisha Pai, Vice President, Communications & Investor Relations 617-510-9193 mpai@magentatx.com Source: Magenta Therapeutics In This StorySee details»
Magenta Therapeutics and Dianthus Therapeutics Announce …
May 3, 2023 Merger to create Nasdaq-listed, clinical-stage biotechnology company focused on advancing Dianthus’ portfolio of next-generation antibody complement therapeutics Combined …See details»
Magenta Therapeutics Appoints Steve Mahoney as Chief Financial …
Nov 9, 2020 Magenta Therapeutics: Lyndsey Scull, Director, Corporate Communications, Magenta Therapeutics 202-213-7086 lscull@magentatx.com Investors: Jill Bertotti, W2O …See details»
Magenta Therapeutics to Explore Strategic Alternatives
CAMBRIDGE, Mass., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Magenta Therapeutics (Nasdaq: MGTA), a clinical-stage biotechnology company focused on improving stem cell …See details»